TI
APEN

Trexquant Investment’s Apollo Endosurgery, Inc. APEN Stock Holding History

Trexquant Investment’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-48,973
Closed -$488K – 1886
2022
Q4 		$488K Buy
+48,973
New +$365K 0.01% 925
2022
Q2 		– Sell
-38,071
Closed -$230K – 1977
2022
Q1 		$230K Buy
38,071
+6,344
+20% +$38.7K 0.01% 1138
2021
Q4 		$267K Buy
31,727
+20,170
+175% +$176K 0.02% 991
2021
Q3 		$105K Buy
+11,557
New +$99.4K 0.01% 1047

Other funds holding APEN

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Trexquant Investment's APEN Position: Q1 2023 in Review

Trexquant Investment sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2023, closing a stake of 48,973 shares — an estimated $488K sold.

Trexquant Investment first reported a position in APEN in Q3 2021 and held it in 4 quarters. The position peaked at $488K in Q4 2022. 89 funds tracked by Wall St. Rank hold APEN as of Q1 2023.

  • Trexquant Investment reported no remaining Apollo Endosurgery, Inc. position as of Q1 2023 after selling out during the quarter.
  • Trexquant Investment sold 48,973 Apollo Endosurgery, Inc. shares in Q1 2023, an estimated $488K.
  • Trexquant Investment first reported a position in Apollo Endosurgery, Inc. in Q3 2021 and held it in 4 quarters.
  • Trexquant Investment's Apollo Endosurgery, Inc. position peaked at $488K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2023.

Based on Trexquant Investment's 13F filing for Q1 2023, filed 15 May 2023.